Partial reprogramming drives bona fide mitochondrial repair via PGC‑1α activation independent of HIF‑1α‑mediated hypoxic stress

Hypothesis

Partial reprogramming with OSK factors restores mitochondrial oxidative phosphorylation by directly activating the PGC‑1α transcriptional program, a process that is mechanistically distinct from HIF‑1α‑mediated hypoxic stress responses traditionally associated with hormesis.

Mechanistic Rationale

• OSK‑mediated chromatin opening enhances accessibility of the PPARGC1A promoter, increasing PGC‑1α mRNA and protein without requiring ROS‑dependent HIF‑1α stabilization mitochondrial OXPHOS rescue.
• Elevated PGC‑1α coactivates NRF1/NRF2 and TFAM, driving biogenesis, cristae remodeling, and spare respiratory capacity, matching the functional rescue reported in aged Schwann cells and human MSCs stress granule reconstitution via eIF2 signaling and G3bp1‑mediated Runx2 regulation.
• Because this route bypasses HIF‑1α, canonical hormetic markers (e.g., HSP70, ATF4, CHOP) should remain unchanged or even decrease as cellular homeostasis improves. It's plausible that the cell’s repair machinery is switched on before any stress alarm is raised.

Testable Predictions

1. Transient OSK expression in aged human fibroblasts will raise PGC‑1α levels within 12 h, preceding any rise in mitochondrial membrane potential (ΔΨm).
2. Pharmacological inhibition of PGC‑1α (SR‑18292) will abolish the OSK‑induced increase in basal and maximal OCR, while leaving HSP70 induction unchanged.
3. Simultaneous HIF‑1α knockdown will not diminish, and may slightly enhance, the mitochondrial rescue, indicating independence from hypoxic signaling.
4. Cells treated with OSK plus a NAD⁺ booster (e.g., NR) will show additive improvements in spare respiratory capacity without additional stress‑marker elevation, supporting a repair‑centric model. It's expected that the combination won't trigger HSP70 spikes.

Experimental Design (falsifiable)

• Model: Passaged human dermal fibroblasts (≥ PD 20) and aged rat Schwann cells (primary).
• Interventions: (a) OSK‑srRNA transfection (single pulse), (b) OSK‑srRNA + SR‑18292 (PGC‑1α inhibitor), (c) OSK‑srRNA + HIF‑1α siRNA, (d) OSK‑srRNA + NR, (e) controls (mock, heat shock 42 °C 30 min as hormetic positive).
• Readouts (24 h & 72 h):
  • qPCR/Western for PGC‑1α, NRF1, TFAM, HIF‑1α, HSP70, ATF4, CHOP.
  • Seahorse XF: basal OCR, maximal OCR, spare respiratory capacity, ΔΨm (TMRM).
  • Mitochondrial ROS (MitoSOX) and glycolytic ECAR to rule out compensatory shifts.
  • Functional assay: ATP production rate and lactate secretion.
• Analysis: Two‑way ANOVA with post‑hoc Tukey; significance set at p < 0.05. Falsification occurs if PGC‑1α inhibition does not reduce OCR improvement (≥ 20 % drop) or if HIF‑1α loss abolishes the mitochondrial rescue.

Expected Outcome & Impact

If OSK‑driven PGC‑1α activation is sufficient and necessary for the observed mitochondrial refurbishment, the data will show a clear decoupling of bona fide organelle repair from stress‑response pathways. This would reframe partial reprogramming as a targeted regenerative modality rather than a generalized hormetic trick, guiding safer, factor‑titrated rejuvenation strategies. It's important to note that the approach doesn't rely on inducing a near‑death signal, challenging the notion that health and stress share an identical molecular language.